ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,567Medicare Part D Prescriptions Filled, Including Refills

Rank: 189 out of 944

$492K Total Retail Price of All Prescriptions

Rank: 221 out of 944

342 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 342 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 342 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 8,432 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 388 371 1 5
LEVOTHYROXINE SODIUM 353 314 2 2
LISINOPRIL 335 316 3 3
PRAVASTATIN SODIUM 334 261 4 17
WARFARIN SODIUM 294 284 5 7
FUROSEMIDE 235 224 6 6
OMEPRAZOLE 195 146 7 4
MIRTAZAPINE 190 187 8 35
HYDROCODONE-ACETAMINOPHEN 185 183 S3 9 10
METOPROLOL SUCCINATE 180 154 10 14
LOSARTAN POTASSIUM 160 145 11 16
SERTRALINE HCL 156 156 12 23
ATORVASTATIN CALCIUM 156 134 12 13
POLYETHYLENE GLYCOL 3350 154 143 14 41
METOPROLOL TARTRATE 139 139 15 8
SIMVASTATIN 124 121 16 1
METFORMIN HCL ER 123 104 17 49
ALLOPURINOL 123 105 17 22
NAMENDA 120 120 19 37
TRAMADOL HCL 119 85 20 21
ZOLPIDEM TARTRATE 117 80 21 25
TAMSULOSIN HCL 113 110 22 27
PANTOPRAZOLE SODIUM 103 86 23 34
DONEPEZIL HCL 103 102 23 24
OXYCODONE-ACETAMINOPHEN 98 82 S2 25 62
ATENOLOL 94 94 26 11
CITALOPRAM HBR 88 88 27 19
DIGOXIN 87 82 28 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 53 29 29
SPIRONOLACTONE 83 55 30 44
GABAPENTIN 82 61 31 18
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 32 54
PREDNISONE 77 73 32 32
ISOSORBIDE MONONITRATE ER 75 64 34 52
CYMBALTA 73 52 35 75
FLUTICASONE PROPIONATE 71 44 36 40
HYDROCHLOROTHIAZIDE 71 71 36 9
SPIRIVA 70 70 38 65
ALENDRONATE SODIUM 69 69 39 20
TRIAMTERENE-HCTZ 68 68 40 33
DIOVAN 68 56 40 38
ADVAIR DISKUS 63 47 42 31
GALANTAMINE HBR 62 62 43 219
CRESTOR 59 45 44 28
PROAIR HFA 57 32 45 56
FLUOXETINE HCL 55 54 46 48
CARVEDILOL 54 42 47 30
POTASSIUM CHLORIDE 54 39 47 15
FENTANYL 53 52 S2 49 57
CLOPIDOGREL 50 49 50 36
VENLAFAXINE HCL ER 50 37 50 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.